AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildablue M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Medcure Pharma

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildablue M 500mg/50mg Tablet

Combiflex DM 500mg/50mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflex DM 500mg/50mg may be administered independently or in conjunction with other anti-diabetic therapies. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Ingestion with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes benefits; cessation should only occur under physician guidance. Effective blood sugar control helps prevent future complications. Adherence to your doctor's dietary and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Common adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect when used with insulin or sulfonylureas; learn its recognition and management. This medication isn't universally suitable. Inform your doctor of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals should seek medical counsel. Drug interactions are possible; disclose all medications to your physician to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Vildablue M 500mg/50mg Tablet

The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Vildablue M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildablue M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 500mg/50mg Vildablue M tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

Common Side effects of Vildablue M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildablue M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Vildablue M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Vildablue M 500mg/50mg Tablet works:

Each Vildablue M 500mg/50mg tablet contains a dual-action formulation of two antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vildablue M 500mg/50mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildablue M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildablue M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Vildablue M 500mg/50mg tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Vildablue M 500mg/50mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildablue M 500mg/50mg Tablet :

Should you forget a Vildablue M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildablue M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vildablue M 500mg/50mg Tablet

Vildablue M 500mg/50mg Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildablue M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Do not take other medications without consulting your doctor.
Vildablue M 500mg/50mg Tablet is contraindicated in patients allergic to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Vildablue M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildablue M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue use and seek immediate medical attention.
Prolonged use of Vildablue M 500mg/50mg Tablet can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological issues.
Vildablue M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vildablue M 500mg/50mg Ta...
91
MRP 105
13% off